Direct fibroblast reprogramming: an emerging strategy for treating organic fibrosis
Haohui Lin,
No information about this author
Xia Wang,
No information about this author
Manhon Chung
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 27, 2025
Direct
reprogramming
has
garnered
considerable
attention
due
to
its
capacity
directly
convert
differentiated
cells
into
desired
cells.
Fibroblasts
are
frequently
employed
in
studies
their
abundance
and
accessibility.
However,
they
also
the
key
drivers
progression
of
fibrosis,
a
pathological
condition
characterized
by
excessive
extracellular
matrix
deposition
tissue
scarring.
Furthermore,
initial
stage
typically
involves
deactivating
fibrotic
pathways.
Hence,
direct
offers
valuable
method
regenerate
target
for
repair
while
simultaneously
reducing
tendencies.
Understanding
link
between
fibrosis
could
help
develop
effective
strategies
treat
damaged
with
potential
risk
fibrosis.
This
review
summarizes
advances
reveals
anti-fibrosis
effects
various
organs
such
as
heart,
liver,
skin.
we
dissect
mechanisms
influenced
molecules
including
TGF-β
signaling,
mechanical
inflammation
epigenetic
modifiers,
metabolic
regulators.
Innovative
methods
fibroblast
like
small
molecules,
CRISPRa,
modified
mRNA,
challenges
cellular
heterogeneity
senescence
faced
vivo
reprogramming,
discussed.
Language: Английский
Epigenetic Regulation of EMP/EMT-Dependent Fibrosis
Published: Jan. 3, 2024
Fibrosis
represents
a
process
characterized
by
excessive
deposition
of
extracellular
matrix
(ECM)
proteins.
It
often
the
evolution
pathological
conditions,
causes
organ
failure,
and
can,
in
extreme
cases,
compromises
functionality
organs
to
point
causing
death.
In
recent
years,
considerable
efforts
have
been
made
understand
molecular
mechanisms
underlying
fibrotic
identify
possible
therapeutic
strategies.
Great
interest
has
aroused
discovery
association
between
epithelial
mesenchymal
plasticity
(EMP),
particular
transition
(EMT),
fibrogenesis,
which
led
identification
complex
closely
interconnected
with
each
other,
could
explain
EMT-dependent
fibrosis.
However,
result
remains
unsatisfactory
from
view.
advances
epigenetics,
is
based
on
chromatin
remodeling
through
various
histone
modifications
or
intervention
non-coding
RNAs
(ncRNAs),
provided
more
information
process,
this
represent
promising
path
forward
for
innovative
strategies
review,
we
summarize
current
research
epigenetic
involved
fibrosis,
focus
regulation
EMP/EMT-dependent
Language: Английский
The Impact of Natriuretic Peptides on Heart Development, Homeostasis, and Disease
Cells,
Journal Year:
2024,
Volume and Issue:
13(11), P. 931 - 931
Published: May 28, 2024
During
mammalian
heart
development,
the
clustered
genes
encoding
peptide
hormones,
Natriuretic
Peptide
A
(NPPA;
ANP)
and
B
(NPPB;
BNP),
are
transcriptionally
co-regulated
co-expressed
predominately
in
atrial
ventricular
trabecular
cardiomyocytes.
After
birth,
expression
of
NPPA
a
natural
antisense
transcript
NPPA-AS1
becomes
restricted
to
Both
NPPB
induced
by
cardiac
stress
serve
as
markers
for
cardiovascular
dysfunction
or
injury.
gene
products
extensively
used
diagnostic
prognostic
biomarkers
various
disorders.
Membrane-localized
guanylyl
cyclase
receptors
on
many
cell
types
throughout
body
mediate
signaling
natriuretic
ligands
through
generation
intracellular
cGMP,
which
interacts
with
modulates
activity
cGMP-activated
kinase
other
enzymes
ion
channels.
The
system
plays
fundamental
role
cardio-renal
homeostasis,
its
potent
diuretic
vasodilatory
effects
provide
compensatory
mechanisms
pathophysiological
conditions
failure.
In
addition,
both
peptides,
but
also
CNP,
have
important
intracardiac
actions
during
development
homeostasis
independent
systemic
functions.
Exploration
functions
may
new
leads
therapeutic
utility
peptide-mediated
diseases
rhythm
Here,
we
review
recent
insights
into
regulation
disease.
Language: Английский
Extracellular Matrix Stiffness: Mechanotransduction and Mechanobiological Response-Driven Strategies for Biomedical Applications Targeting Fibroblast Inflammation
Polymers,
Journal Year:
2025,
Volume and Issue:
17(6), P. 822 - 822
Published: March 20, 2025
The
extracellular
matrix
(ECM)
is
a
dynamic
network
providing
mechanical
and
biochemical
cues
that
regulate
cellular
behavior.
ECM
stiffness
critically
influences
fibroblasts,
the
primary
producers,
particularly
in
inflammation
fibrosis.
This
review
explores
role
of
fibroblast-driven
tissue
remodeling,
focusing
on
physicochemical
biological
mechanisms
involved.
Engineered
materials,
hydrogels,
polydimethylsiloxane
(PDMS)
are
highlighted
for
replicating
tissue-specific
stiffness,
enabling
precise
control
over
cell–matrix
interactions.
surface
functionalization
substrate
including
collagen,
polydopamine,
fibronectin,
enhances
bioactivity
fibroblast
adhesion.
Key
mechanotransduction
pathways,
such
as
integrin
signaling
YAP/TAZ
activation,
related
to
regulating
behaviors
inflammatory
responses.
fibroblasts
driving
chronic
diseases
emphasizes
their
therapeutic
potentials.
Advances
ECM-modifying
strategies,
tunable
biomaterials
hydrogel-based
therapies,
explored
applications
engineering,
drug
delivery,
anti-inflammatory
treatments,
diagnostic
tools
accurate
diagnosis
prognosis
stiffness-related
diseases.
integrates
mechanobiology
with
biomedical
innovations,
comprehensive
responses
outlining
future
directions
targeted
therapies.
Language: Английский
The epigenetic regulation of crosstalk between cardiac fibroblasts and other cardiac cell types during stress
Lindsay Kraus,
No information about this author
Salim Fredericks,
No information about this author
Katelyn Scheeler
No information about this author
et al.
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: April 8, 2025
With
the
global
impact
of
cardiovascular
disease,
there
is
a
dire
need
to
understand
mechanisms
in
heart
during
injury
and
stress.
It
has
been
shown
that
regulation
extracellular
matrix
via
cardiac
fibroblasts
plays
major
role
progression
failure
worsening
function
heart.
Importantly,
it
suggested
crosstalk
between
other
cells
like
cardiomyocytes,
immune
cells,
endothelial
are
influenced
by
pathological
fibroblasts.
This
decline
across
all
seemingly
irreversible.
However,
epigenetic
have
regulate
functionality
improve
outcomes
stress
or
injury.
also
control
communication
different
cell
types
influence
multiple
The
goal
this
review
summarize
discuss
current
research
subsequent
with
disease
states.
Language: Английский
IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice
Qingyu Huang,
No information about this author
Tongqing Chen,
No information about this author
Jian Li
No information about this author
et al.
Journal of Translational Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: May 24, 2024
Diabetic
cardiomyopathy
(DCM),
a
serious
complication
of
diabetes,
leads
to
structural
and
functional
abnormalities
the
heart
ultimately
evolves
failure.
IL-37
exerts
substantial
influence
on
regulation
inflammation
metabolism.
Whether
is
involved
in
DCM
unknown.
Language: Английский
Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases
Sumra Komal,
No information about this author
Yuan Gao,
No information about this author
Zhi-Mo Wang
No information about this author
et al.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(10), P. 1353 - 1353
Published: Oct. 10, 2024
Myocardial
fibroblasts
play
a
crucial
role
in
heart
structure
and
function.
In
recent
years,
significant
progress
has
been
made
understanding
the
epigenetic
regulation
of
myocardial
fibroblasts,
which
is
essential
for
cardiac
development,
homeostasis,
disease
progression.
healthy
hearts,
(CFs)
synthesizing
extracellular
matrix
(ECM)
when
dormant
state.
However,
under
pathological
environmental
stress,
CFs
transform
into
activated
known
as
myofibroblasts.
These
myofibroblasts
produce
an
excess
ECM,
promotes
fibrosis.
Although
multiple
molecular
mechanisms
are
associated
with
CF
activation
dysfunction,
emerging
evidence
highlights
involvement
this
process.
Epigenetics
refers
to
heritable
changes
gene
expression
that
occur
without
altering
DNA
sequence.
have
emerged
key
regulators
fibroblast
This
review
focuses
on
advancements
emphasizes
impact
modifications
activation.
Furthermore,
we
present
perspectives
prospects
future
research
their
implications
fibroblasts.
Language: Английский
Rap2a promotes cardiac fibrosis and exacerbates myocardial infarction through the TNIK/Merlin/YAP axis
Zhibin Lang,
No information about this author
Xiaozhen Fan,
No information about this author
Lin Qiu
No information about this author
et al.
Cell Biology and Toxicology,
Journal Year:
2025,
Volume and Issue:
41(1)
Published: May 7, 2025
Myocardial
fibrosis
constitutes
the
primary
pathological
characteristic
of
myocardial
infarction
(MI).
The
activation
and
proliferation
fibroblasts
serve
as
crucial
factors
in
process
development
myocardium.
Our
research
delved
into
role
that
Rap2a
plays
cardiac
function
well
fibrosis,
while
its
effects
on
cardial
(CFs)
proliferation,
migration,
phenotypic
transformation
were
also
explored.
Examination
GEO
database
showed
a
notable
increase
expression
within
tissue
from
mice
with
MI
compared
to
normal
mice.
deficiency
relieves
restrains
transition,
migration
CFs.
absence
mitigates
Besides,
it
curbs
growth
CFs,
restricts
their
movement,
prevents
them
undergoing
conversion.
can
bind
TNIK
enhance
expression;
Merlin/YAP
signaling
pathway
was
assessed
downstream
target
further
elucidate
regulatory
mechanism
through
which
influences
cardiomyocytes.
In
conclusion,
this
study
provides
evidence
promotes
mediating
myofibroblast
transformation,
CFs
via
TNIK/Merlin/YAP
pathway,
thereby
exacerbating
symptoms
infarction.
Language: Английский
Epigenetic Regulation of EMP/EMT-Dependent Fibrosis
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2775 - 2775
Published: Feb. 28, 2024
Fibrosis
represents
a
process
characterized
by
excessive
deposition
of
extracellular
matrix
(ECM)
proteins.
It
often
the
evolution
pathological
conditions,
causes
organ
failure,
and
can,
in
extreme
cases,
compromise
functionality
organs
to
point
causing
death.
In
recent
years,
considerable
efforts
have
been
made
understand
molecular
mechanisms
underlying
fibrotic
identify
possible
therapeutic
strategies.
Great
interest
has
aroused
discovery
association
between
epithelial
mesenchymal
plasticity
(EMP),
particular
transition
(EMT),
fibrogenesis,
which
led
identification
complex
closely
interconnected
with
each
other,
could
explain
EMT-dependent
fibrosis.
However,
result
remains
unsatisfactory
from
view.
advances
epigenetics,
based
on
chromatin
remodeling
through
various
histone
modifications
or
intervention
non-coding
RNAs
(ncRNAs),
provided
more
information
process,
this
represent
promising
path
forward
for
innovative
strategies
review,
we
summarize
current
research
epigenetic
involved
fibrosis,
focus
regulation
EMP/EMT-dependent
Language: Английский
IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice
Bang wei Wu,
No information about this author
Qingyu Huang,
No information about this author
Tongqing Chen
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 9, 2024
Abstract
Background
Diabetic
cardiomyopathy
(DCM),
a
serious
complication
of
diabetes,
leads
to
structural
and
functional
abnormalities
the
heart
ultimately
evolves
failure.
Currently,
treatment
options
for
DCM
remain
limited.
IL-37
exerts
substantial
influence
on
regulation
inflammation
metabolism.
Whether
is
involved
in
unknown.
Methods
The
plasma
samples
were
collected
from
healthy
controls,
diabetic
patients
patients,
level
its
relationship
with
function
observed.
changes
cardiac
function,
myocardial
fibrosis
mitochondrial
injury
mice
or
without
intervention
investigated
vivo.
By
an
vitro
co-culture
approach
involving
HG
challenge
cardiomyocytes
fibroblasts,
interaction
carried
out
by
fibroblast
profibrotic
activation
was
studied.
Finally,
possible
interactive
mediator
between
fibroblasts
explored,
role
relevant
molecular
mechanisms.
Results
We
showed
that
upregulated
compared
controls
patients.
Both
recombinant
administration
inducing
expression
alleviated
dysfunction
mice.
Mechanically,
hyperglycemia
impaired
mitochondria
through
SIRT1/AMPK/PGC1α
signaling,
resulting
significant
cardiomyocyte
apoptosis
release
extracellular
vesicles
containing
mtDNA.
Fibroblasts
then
engulfed
these
mtDNA-enriched
vesicles,
thereby
activating
TLR9
signaling
cGAS-STING
pathway
initiate
pro-fibrotic
process
adverse
remodeling.
However,
presence
ameliorated
preserving
activity
SIRT1-AMPK-PGC1α
axis,
reduction
vesicle
attenuating
progression
DCM.
Conclusions
Collectively,
our
study
demonstrates
protective
DCM,
offering
promising
therapeutic
agent
this
disease.
Language: Английский